$AERT
Aeries Technology, Inc. Stock $aert

$aert Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000182912624007681 Filed on November 19, 2024

Income Statement

Concept	2024 Q3	2023 Q3
Revenue	$16.87M
YoY Change
Cost Of Revenue	$13.30M	$12.75M
YoY Change	4.27%
Gross Profit	$3.575M	$4.824M
YoY Change	-25.89%
Gross Profit Margin	21.19%
Selling, General & Admin	$7.670M	$1.597M
YoY Change	380.13%	10.6%
% of Gross Profit	214.55%	33.12%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$371.0K	$334.0K
YoY Change	11.08%
% of Gross Profit	10.38%	6.92%
Operating Expenses	$7.670M	$1.597M
YoY Change	380.13%	10.6%
Operating Profit	-$4.095M	-$1.597M
YoY Change	156.34%	10.6%
Interest Expense	$135.0K	$75.62K
YoY Change	78.52%	-91.54%
% of Operating Profit
Other Income/Expense, Net	$1.263M	$0.00
YoY Change		-100.0%
Pretax Income	-$2.832M	-$1.522M
YoY Change	86.09%	337.22%
Income Tax	-$526.0K	$679.0K
% Of Pretax Income
Net Earnings	-$2.280M	-$1.522M
YoY Change	49.82%	337.22%
Net Earnings / Revenue	-13.51%
Basic Earnings Per Share	-$0.05
Diluted Earnings Per Share	-$0.05	-$0.15
COMMON SHARES
Basic Shares Outstanding	44.50M shares
Diluted Shares Outstanding	44.36M shares

Balance Sheet

Concept	2024 Q3	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.627M	$8.410K
YoY Change	43027.23%	-91.0%
Cash & Equivalents	$3.627M	$8.412K
Short-Term Investments
Other Short-Term Assets	$7.343M	$837.00
YoY Change	877199.88%	-99.79%
Inventory
Prepaid Expenses		$39.85K
Receivables	$18.48M	$14.38M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$29.45M	$49.09K
YoY Change	59880.85%	-89.98%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.728M	$9.528M
YoY Change	-60.87%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$1.717M	$49.99M
YoY Change	-96.57%	-78.58%
Other Assets	$4.683M	$4.033M
YoY Change	16.12%	20365.85%
Total Long-Term Assets	$22.51M	$49.99M
YoY Change	-54.97%	-78.59%
TOTAL ASSETS
Total Short-Term Assets	$29.45M	$49.09K
Total Long-Term Assets	$22.51M	$49.99M
Total Assets	$51.96M	$50.04M
YoY Change	3.83%	-78.61%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$7.330M	$6.352M
YoY Change	15.4%	20161.11%
Accrued Expenses	$4.257M	$62.27K
YoY Change	6736.69%	-96.02%
Deferred Revenue
YoY Change
Short-Term Debt	$4.482M	$557.8K
YoY Change	703.5%	176.2%
Long-Term Debt Due	$1.514M	$13.00K
YoY Change	11546.15%
Total Short-Term Liabilities	$39.22M	$9.386M
YoY Change	317.87%	422.38%
LONG-TERM LIABILITIES
Long-Term Debt	$1.514M	$0.00
YoY Change
Other Long-Term Liabilities	$4.462M	$1.002M
YoY Change	345.47%	-54.04%
Total Long-Term Liabilities	$5.976M	$1.002M
YoY Change	496.62%	-54.04%
TOTAL LIABILITIES
Total Short-Term Liabilities	$39.22M	$9.386M
Total Long-Term Liabilities	$5.976M	$1.002M
Total Liabilities	$53.27M	$10.39M
YoY Change	412.84%	161.25%
SHAREHOLDERS EQUITY
Retained Earnings	-$28.68M	-$10.24M
YoY Change	180.08%	204.1%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$2.316M	-$10.24M
YoY Change
Total Liabilities & Shareholders Equity	$51.96M	$50.04M
YoY Change	3.83%	-78.61%

Cashflow Statement

Concept	2024 Q3	2023 Q3
OPERATING ACTIVITIES
Net Income	-$2.280M	-$1.522M
YoY Change	49.82%	337.22%
Depreciation, Depletion And Amortization	$371.0K	$334.0K
YoY Change	11.08%
Cash From Operating Activities	$1.925M	-$33.44K
YoY Change	-5856.58%	-25.64%
INVESTING ACTIVITIES
Capital Expenditures	$612.0K	$476.0K
YoY Change	28.57%
Acquisitions
YoY Change
Other Investing Activities	$232.0K	$0.00
YoY Change
Cash From Investing Activities	-$380.0K	$0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-2.136M	0.000
YoY Change
NET CHANGE
Cash From Operating Activities	1.925M	-33.44K
Cash From Investing Activities	-380.0K	0.000
Cash From Financing Activities	-2.136M	0.000
Net Change In Cash	-591.0K	-33.44K
YoY Change	1667.34%	-25.64%
FREE CASH FLOW
Cash From Operating Activities	$1.925M	-$33.44K
Capital Expenditures	$612.0K	$476.0K
Free Cash Flow	$1.313M	-$509.4K
YoY Change	-357.73%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity File Number EntityFileNumber	001-40920
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	E9
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-1587626
	dei	Entity Address Address Line1 EntityAddressAddressLine1	60 Paya Lebar Road
	dei	Entity Address Address Line3 EntityAddressAddressLine3	Paya Lebar Square
	dei	Entity Address City Or Town EntityAddressCityOrTown	Singapore
	dei	Entity Address Country EntityAddressCountry	SG
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	409051
	dei	City Area Code CityAreaCode	919
	dei	Local Phone Number LocalPhoneNumber	228-6404
	us-gaap	Interest Expense InterestExpense	199000	usd
CY2024Q3	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	59000	usd
CY2023Q3	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	126000	usd
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-31
	dei	Entity Central Index Key EntityCentralIndexKey	0001853044
CY2024Q3	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue		usd
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity Registrant Name EntityRegistrantName	Aeries Technology, Inc.
	dei	Entity Address Address Line2 EntityAddressAddressLine2	#08-13
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2024Q3	us-gaap	Accounts Receivable Net AccountsReceivableNet	18477000	usd
CY2024Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	23757000	usd
CY2024Q3	aert	Prepaid Expenses And Other Current Assets Net Of Allowance PrepaidExpensesAndOtherCurrentAssetsNetOfAllowance	1000	usd
CY2024Q1	aert	Prepaid Expenses And Other Current Assets Net Of Allowance PrepaidExpensesAndOtherCurrentAssetsNetOfAllowance	1000	usd
CY2024Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7343000	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6995000	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	29447000	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	32836000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3728000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3579000	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	8486000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7318000	usd
CY2024Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	3899000	usd
CY2024Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1933000	usd
CY2024Q3	aert	Longterm Investments Net Of Allowance LongtermInvestmentsNetOfAllowance	117000	usd
CY2024Q1	aert	Longterm Investments Net Of Allowance LongtermInvestmentsNetOfAllowance	126000	usd
CY2024Q1	us-gaap	Long Term Investments LongTermInvestments	1612000	usd
CY2024Q3	aert	Other Assets Net Of Allowance OtherAssetsNetOfAllowance	1000	usd
CY2024Q1	aert	Other Assets Net Of Allowance OtherAssetsNetOfAllowance	1000	usd
CY2024Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4683000	usd
CY2024Q3	us-gaap	Assets Assets	51960000	usd
CY2024Q1	us-gaap	Assets Assets	49407000	usd
CY2024Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	7330000	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	6616000	usd
CY2024Q3	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	2603000	usd
CY2024Q1	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	3119000	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1654000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2080000	usd
CY2024Q3	us-gaap	Short Term Borrowings ShortTermBorrowings	4482000	usd
CY2024Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	6778000	usd
CY2024Q3	aert	Forward Purchase Agreement Put Option Liability ForwardPurchaseAgreementPutOptionLiability	9563000	usd
CY2024Q1	aert	Forward Purchase Agreement Put Option Liability ForwardPurchaseAgreementPutOptionLiability	10244000	usd
CY2024Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	13591000	usd
CY2024Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	9288000	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	39223000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	38125000	usd
CY2024Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1440000	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	7209000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5615000	usd
CY2024Q3	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	736000	usd
CY2024Q1	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	1367000	usd
CY2024Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	130000	usd
CY2024Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	92000	usd
CY2024Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	4462000	usd
CY2024Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3948000	usd
CY2024Q3	us-gaap	Liabilities Liabilities	53274000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	50587000	usd
CY2024Q3	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	685000	usd
CY2024Q1	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	734000	usd
CY2024Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2024Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
	us-gaap	Revenues Revenues	33908000	usd
CY2024Q3	us-gaap	Cost Of Revenue CostOfRevenue	13298000	usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	12754000	usd
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2025
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		usd
CY2023Q3	aert	Change In Fair Value Of Forward Purchase Agreement Put Option Liability ChangeInFairValueOfForwardPurchaseAgreementPutOptionLiability		usd
	aert	Change In Fair Value Of Forward Purchase Agreement Put Option Liability ChangeInFairValueOfForwardPurchaseAgreementPutOptionLiability		usd
CY2023Q3	aert	Change In Fair Value Of Derivative Warrant Liabilities ChangeInFairValueOfDerivativeWarrantLiabilities		usd
	aert	Change In Fair Value Of Derivative Warrant Liabilities ChangeInFairValueOfDerivativeWarrantLiabilities		usd
CY2023Q3	aert	Less Net Income Attributable To Redeemable Noncontrolling Interests LessNetIncomeAttributableToRedeemableNoncontrollingInterests		usd
	aert	Less Net Income Attributable To Redeemable Noncontrolling Interests LessNetIncomeAttributableToRedeemableNoncontrollingInterests		usd
CY2023Q3	aert	Comprehensive Income Attributable To Redeemable Noncontrolling Interests ComprehensiveIncomeAttributableToRedeemableNoncontrollingInterests		usd
	aert	Comprehensive Income Attributable To Redeemable Noncontrolling Interests ComprehensiveIncomeAttributableToRedeemableNoncontrollingInterests		usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities		usd
	aert	Change In Fair Value Of Derivative Warrants Liabilities ChangeInFairValueOfDerivativeWarrantsLiabilities		usd
	aert	Loss On Issuance Of Shares Against Accounts Payable LossOnIssuanceOfSharesAgainstAccountsPayable		usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts		usd
	aert	Net Changes In Net Shareholders Investment NetChangesInNetShareholdersInvestment		usd
	us-gaap	Proceeds From Sales Of Business Affiliate And Productive Assets ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets		usd
	aert	Settlement Of Accounts Payable Through Issuance Of Class Ordinary Shares To Vendors SettlementOfAccountsPayableThroughIssuanceOfClassOrdinarySharesToVendors		usd
	dei	Document Type DocumentType	10-Q
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	44500426	shares
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3627000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2084000	usd
CY2024Q3	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	4844000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	1263000	usd
CY2024Q3	us-gaap	Long Term Investments LongTermInvestments	1717000	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2129000	usd
CY2024Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1514000	usd
CY2024Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	27159000	usd
CY2024Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-800000	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-574000	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-28679000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-11668000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	-2316000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-12240000	usd
CY2024Q3	us-gaap	Minority Interest MinorityInterest	317000	usd
CY2024Q1	us-gaap	Minority Interest MinorityInterest	10326000	usd
CY2024Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1999000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1914000	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	51960000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	49407000	usd
CY2024Q3	us-gaap	Revenues Revenues	16873000	usd
CY2023Q3	us-gaap	Revenues Revenues	17578000	usd
	us-gaap	Revenues Revenues	33540000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	25955000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	24637000	usd
CY2024Q3	us-gaap	Gross Profit GrossProfit	3575000	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	4824000	usd
	us-gaap	Gross Profit GrossProfit	7585000	usd
	us-gaap	Gross Profit GrossProfit	9271000	usd
CY2024Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7670000	usd
CY2023Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3338000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	28100000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7008000	usd
CY2024Q3	us-gaap	Operating Expenses OperatingExpenses	7670000	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	3338000	usd
	us-gaap	Operating Expenses OperatingExpenses	28100000	usd
	us-gaap	Operating Expenses OperatingExpenses	7008000	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-4095000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	1486000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-20515000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	2263000	usd
CY2024Q3	aert	Change In Fair Value Of Forward Purchase Agreement Put Option Liability ChangeInFairValueOfForwardPurchaseAgreementPutOptionLiability	1377000	usd
	aert	Change In Fair Value Of Forward Purchase Agreement Put Option Liability ChangeInFairValueOfForwardPurchaseAgreementPutOptionLiability	681000	usd
CY2024Q3	aert	Change In Fair Value Of Derivative Warrant Liabilities ChangeInFairValueOfDerivativeWarrantLiabilities	-126000	usd
	aert	Change In Fair Value Of Derivative Warrant Liabilities ChangeInFairValueOfDerivativeWarrantLiabilities	631000	usd
CY2024Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	88000	usd
CY2023Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	70000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	167000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	134000	usd
CY2024Q3	us-gaap	Interest Expense InterestExpense	135000	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	76000	usd
	us-gaap	Interest Expense InterestExpense	282000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	78000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	120000	usd
CY2024Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1263000	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	120000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1275000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	55000	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2832000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1606000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-19240000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2318000	usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-526000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	679000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1617000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	897000	usd
CY2024Q3	us-gaap	Profit Loss ProfitLoss	-2306000	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	927000	usd
	us-gaap	Profit Loss ProfitLoss	-17623000	usd
	us-gaap	Profit Loss ProfitLoss	1421000	usd
CY2024Q3	us-gaap	Income Loss Attributable To Noncontrolling Interest IncomeLossAttributableToNoncontrollingInterest	-90000	usd
CY2023Q3	us-gaap	Income Loss Attributable To Noncontrolling Interest IncomeLossAttributableToNoncontrollingInterest	108000	usd
	us-gaap	Income Loss Attributable To Noncontrolling Interest IncomeLossAttributableToNoncontrollingInterest	-596000	usd
	us-gaap	Income Loss Attributable To Noncontrolling Interest IncomeLossAttributableToNoncontrollingInterest	181000	usd
CY2024Q3	aert	Less Net Income Attributable To Redeemable Noncontrolling Interests LessNetIncomeAttributableToRedeemableNoncontrollingInterests	-26000	usd
	aert	Less Net Income Attributable To Redeemable Noncontrolling Interests LessNetIncomeAttributableToRedeemableNoncontrollingInterests	-16000	usd
CY2024Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2190000	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	819000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-17011000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1240000	usd
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	44356074	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	44356074	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41121826	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41121826	shares
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.42
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.42
CY2024Q3	us-gaap	Profit Loss ProfitLoss	-2306000	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	927000	usd
	us-gaap	Profit Loss ProfitLoss	-17623000	usd
	us-gaap	Profit Loss ProfitLoss	1421000	usd
CY2024Q3	us-gaap	Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent	129000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent	186000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent	191000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent	153000	usd
CY2024Q3	aert	Unrecognized Actuarial Gain Loss On Employee Benefit Plan Obligations UnrecognizedActuarialGainLossOnEmployeeBenefitPlanObligations	-64000	usd
CY2023Q3	aert	Unrecognized Actuarial Gain Loss On Employee Benefit Plan Obligations UnrecognizedActuarialGainLossOnEmployeeBenefitPlanObligations	-6000	usd
	aert	Unrecognized Actuarial Gain Loss On Employee Benefit Plan Obligations UnrecognizedActuarialGainLossOnEmployeeBenefitPlanObligations	-85000	usd
	aert	Unrecognized Actuarial Gain Loss On Employee Benefit Plan Obligations UnrecognizedActuarialGainLossOnEmployeeBenefitPlanObligations	-53000	usd
CY2024Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-193000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-192000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-276000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-206000	usd
CY2024Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-2499000	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	735000	usd
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-17899000	usd
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	1215000	usd
CY2024Q3	aert	Comprehensive Income Attributable To Noncontrolling Interests ComprehensiveIncomeAttributableToNoncontrollingInterests	100000	usd
CY2023Q3	aert	Comprehensive Income Attributable To Noncontrolling Interests ComprehensiveIncomeAttributableToNoncontrollingInterests	-80000	usd
	aert	Comprehensive Income Attributable To Noncontrolling Interests ComprehensiveIncomeAttributableToNoncontrollingInterests	613000	usd
	aert	Comprehensive Income Attributable To Noncontrolling Interests ComprehensiveIncomeAttributableToNoncontrollingInterests	-151000	usd
CY2024Q3	aert	Comprehensive Income Attributable To Redeemable Noncontrolling Interests ComprehensiveIncomeAttributableToRedeemableNoncontrollingInterests	50000	usd
	aert	Comprehensive Income Attributable To Redeemable Noncontrolling Interests ComprehensiveIncomeAttributableToRedeemableNoncontrollingInterests	49000	usd
CY2024Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2349000	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	655000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-17237000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1064000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1914000	usd
CY2024Q2	aert	Net Loss For Period Prior To Share Exchange NetLossForPeriodPriorToShareExchange	-674000	usd
CY2024Q2	aert	Other Comprehensive Loss For Period Prior To Share Exchange OtherComprehensiveLossForPeriodPriorToShareExchange	-3000	usd
CY2024Q2	aert	Issuance Of Class Ordinary Shares With Respect To Share Exchange Agreement IssuanceOfClassOrdinarySharesWithRespectToShareExchangeAgreement	2000	usd
CY2024Q2	aert	Issuance Of Class Ordinary Shares In Connection With Private Placement IssuanceOfClassOrdinarySharesInConnectionWithPrivatePlacement	4675000	usd
CY2024Q2	aert	Settlement Of Accounts Payable Through Issuance Of Class Ordinary Shares SettlementOfAccountsPayableThroughIssuanceOfClassOrdinaryShares	78000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	12746000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-14653000	usd
CY2024Q2	aert	Other Comprehensive Loss For Period Post Share Exchange OtherComprehensiveLossForPeriodPostShareExchange	-71000	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	186000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-2280000	usd
CY2024Q3	aert	Other Comprehensive Loss OtherComprehensiveLoss	-169000	usd
CY2024Q3	aert	Issuance Of Class Ordinary Shares In Connection With Private Placement IssuanceOfClassOrdinarySharesInConnectionWithPrivatePlacement	0	usd
CY2024Q3	aert	Settlement Of Accounts Payable Through Issuance Of Class Ordinary Shares SettlementOfAccountsPayableThroughIssuanceOfClassOrdinaryShares	264000	usd
CY2024Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1999000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	13469000	usd
CY2023Q2	aert	Transition Period Adjustment Pursuant To Asc326 Net Of Tax TransitionPeriodAdjustmentPursuantToAsc326NetOfTax	-223000	usd
CY2023Q2	aert	Adjusted Balances AdjustedBalances	13246000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	494000	usd
CY2023Q2	aert	Other Comprehensive Loss OtherComprehensiveLoss	-14000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1374000	usd
CY2023Q2	aert	Net Changes In Net Stockholders Investment NetChangesInNetStockholdersInvestment	-10000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	15090000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	927000	usd
CY2023Q3	aert	Other Comprehensive Loss OtherComprehensiveLoss	-192000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	252000	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	16077000	usd
	us-gaap	Profit Loss ProfitLoss	-17623000	usd
	us-gaap	Profit Loss ProfitLoss	1421000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	745000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	661000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	12746000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1626000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1907000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-81000	usd
	aert	Accrued Income From Longterm Investments AccruedIncomeFromLongtermInvestments	106000	usd
	aert	Accrued Income From Longterm Investments AccruedIncomeFromLongtermInvestments	92000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	3579000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	15000	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	6000	usd
	aert	Others Others	-29000	usd
	aert	Others Others	-18000	usd
	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	-631000	usd
	aert	Change In Fair Value Of Derivative Warrants Liabilities ChangeInFairValueOfDerivativeWarrantsLiabilities	681000	usd
	aert	Loss On Issuance Of Shares Against Accounts Payable LossOnIssuanceOfSharesAgainstAccountsPayable	342000	usd
	aert	Unrealized Exchange Gain Loss UnrealizedExchangeGainLoss	-40000	usd
	aert	Unrealized Exchange Gain Loss UnrealizedExchangeGainLoss	-53000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1264000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1229000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	454000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3209000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	2146000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	631000	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	2557000	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	360000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	863000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-996000	usd
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	-473000	usd
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	-429000	usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	4552000	usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	3377000	usd
	us-gaap	Increase Decrease In Operating Liabilities IncreaseDecreaseInOperatingLiabilities	2176000	usd
	us-gaap	Increase Decrease In Operating Liabilities IncreaseDecreaseInOperatingLiabilities	724000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	591000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	661000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	205000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1387000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	982000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	734000	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	7000	usd
	aert	Issuance Of Loans To Affiliates IssuanceOfLoansToAffiliates	866000	usd
	aert	Issuance Of Loans To Affiliates IssuanceOfLoansToAffiliates	769000	usd
	aert	Payments Received For Loans To Affiliates PaymentsReceivedForLoansToAffiliates	853000	usd
	aert	Payments Received For Loans To Affiliates PaymentsReceivedForLoansToAffiliates	694000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-988000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-809000	usd
	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	-1855000	usd
	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	1270000	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	440000	usd
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	916000	usd
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	575000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	820000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	282000	usd
	us-gaap	Repayments Of Long Term Debt And Capital Securities RepaymentsOfLongTermDebtAndCapitalSecurities	210000	usd
	us-gaap	Repayments Of Long Term Debt And Capital Securities RepaymentsOfLongTermDebtAndCapitalSecurities	211000	usd
	aert	Payment Of Deferred Transaction Costs PaymentOfDeferredTransactionCosts	20000	usd
	aert	Payment Of Deferred Transaction Costs PaymentOfDeferredTransactionCosts	1147000	usd
	aert	Net Changes In Net Shareholders Investment NetChangesInNetShareholdersInvestment	10000	usd
	us-gaap	Proceeds From Sales Of Business Affiliate And Productive Assets ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets	4678000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2249000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	195000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	77000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-22000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1543000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	751000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2084000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1131000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3627000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1882000	usd
	us-gaap	Interest Paid Net InterestPaidNet	321000	usd
	us-gaap	Interest Paid Net InterestPaidNet	178000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	556000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	625000	usd
	aert	Unpaid Deferred Transaction Costs Included In Accounts Payable And Other Current Liabilities UnpaidDeferredTransactionCostsIncludedInAccountsPayableAndOtherCurrentLiabilities	640000	usd
	aert	Unpaid Deferred Transaction Costs Included In Accounts Payable And Other Current Liabilities UnpaidDeferredTransactionCostsIncludedInAccountsPayableAndOtherCurrentLiabilities	1454000	usd
	aert	Equipment Acquired Under Finance Lease Obligations EquipmentAcquiredUnderFinanceLeaseObligations	38000	usd
	aert	Equipment Acquired Under Finance Lease Obligations EquipmentAcquiredUnderFinanceLeaseObligations	235000	usd
	aert	Property And Equipment Purchase Included In Accounts Payable PropertyAndEquipmentPurchaseIncludedInAccountsPayable	1000	usd
	aert	Property And Equipment Purchase Included In Accounts Payable PropertyAndEquipmentPurchaseIncludedInAccountsPayable	4000	usd
	aert	Settlement Of Accounts Payable Through Issuance Of Class Ordinary Shares To Vendors SettlementOfAccountsPayableThroughIssuanceOfClassOrdinarySharesToVendors	342000	usd
	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_808_eus-gaap--NatureOfOperations_zEAeGBmmMANj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 1 - <span id="xdx_82A_zgt9OjriooM3">Nature of Operations</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Unless the context otherwise requires, Aeries Technology, Inc. (formerly Worldwide Webb Acquisition Corp. (“WWAC”), formed in the Cayman Islands on March 5, 2021) and its subsidiaries, excluding the fintech and investing business activities, is herein referred to as the “Company”, “ATI”, the “registrant”, “us,” “we” and “our” in these consolidated financial statements. Aark Singapore Pte. Ltd., a Singapore private company limited by shares (“AARK”) and its subsidiaries, excluding the fintech and investing business activities, is herein referred to as the “Carve-out Entity”. The Company is a global provider of professional and management services and technology consulting, specializing in the establishment and management of dedicated delivery centers known as “Global Capability Centers” (“GCCs”) for portfolio companies of private equity firms and mid-market enterprises. Our engagement models are designed to provide a mix of deep vertical specialty, functional expertise, and digital systems and solutions to scale, optimize and transform a client’s business operations. The Company has subsidiaries in India, Mexico, Singapore, UAE and the United States.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> Business Combination</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 11, 2023, WWAC entered into a Business Combination Agreement (as amended, the “Merger Agreement”) with WWAC Amalgamation Sub Pte. Ltd., a Singapore private company limited by shares and a direct wholly owned subsidiary of WWAC (“Amalgamation Sub”), and AARK. Pursuant to the Merger Agreement, Amalgamation Sub and AARK amalgamated and continued as one company, with AARK being the surviving entity, and as a result thereof, Aeries Technology Group Business Accelerators Pvt. Ltd., an Indian private company limited by shares became an indirect subsidiary of WWAC (the “Amalgamation” and, together with the other transactions contemplated by the Merger Agreement, the “Business Combination”). Following the closing of the Business Combination, WWAC changed its corporate name to Aeries Technology, Inc.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Pursuant to the Merger Agreement, all AARK ordinary shares that were issued and outstanding prior to the effective time of the Amalgamation remained issued and outstanding following the Amalgamation and continued to be held by the former sole shareholder of AARK. The Company issued a Class V ordinary share to NewGen Advisors and Consultants DWC-LLC (“NewGen”). NewGen is a business associate of Mr. Raman Kumar (the “Former AARK Sole Shareholder”). NewGen has agreed to hold the Class V ordinary share to protect the interest of the Former AARK Sole Shareholder, in the event of certain extraordinary events as described in ATI’s amended and restated memorandum and articles of association, including a hostile takeover or the appointment or removal of directors at ATI level. While the Class V ordinary share does not carry any direct economic rights, it does carry voting rights equal to 1.3% which will ratchet up to 51% voting rights upon occurrence of the extraordinary events described above at the ATI level. All of the shares of Amalgamation Sub that were issued and outstanding as of the transaction date were converted into a number of newly issued AARK ordinary shares. In accordance with principles of Financial Accounting Standards Board’s Accounting Standards Codification Topic 805, Business Combinations (“ASC 805”) and based on the economic interest held by the shareholders post the transaction as well as the underlying rights, it was assessed that AARK is the accounting acquirer and WWAC is the accounting acquiree. The Business Combination closed on November 6, 2023 (“Closing Date”) and resulted in ATI owning <span id="xdx_90A_eus-gaap--MinorityInterestOwnershipPercentageByNoncontrollingOwners_c20231106__srt--OwnershipAxis__custom--AARKMember_pdd" title="Ownership, percentage">38.24%</span> of the issued and outstanding shares of AARK and the Former AARK Sole Shareholder of AARK owning the balance <span id="xdx_909_eus-gaap--MinorityInterestOwnershipPercentageByNoncontrollingOwners_c20231106__srt--OwnershipAxis__custom--AARKShareholdersMember_pdd" title="Ownership, percentage">61.76%</span>. Pursuant to the Business Combination, ATI has a right to appoint two out of the three directors on the board of directors of AARK and therefore has an ability to control the activities undertaken by AARK in ordinary course of business, resulting in AARK being classified as a subsidiary of ATI. Finally, the Business Combination has been accounted for as reverse recapitalization. Refer to the section <i>“Reverse Recapitalization”</i> below for details.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Reverse Recapitalization</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As mentioned above – <i> Business Combination</i>, the Business Combination was closed on November 6, 2023 and has been accounted for as a reverse recapitalization because AARK has been determined to be the accounting acquirer under ASC 805 based on the evaluation of the following facts and circumstances taken into consideration:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in">●</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">The Former AARK Sole Shareholder, who controlled AARK prior to the Business Combination, will retain a majority of the outstanding shares of ATI after giving effect to the Exchange Agreements. The Exchange Agreements are further discussed in Note 10;</td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in">●</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">AARK has the ability to elect a majority of the members of ATI’s governing body;</td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in">●</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">AARK’s executive team makes up the executive team of ATI;</td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in">●</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">AARK represents an operating entity (group) with operating assets, revenues, and earnings significantly larger than WWAC.</td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Under a reverse recapitalization, while ATI was the legal acquirer, it has been treated as the “acquired” company for financial reporting purposes. Accordingly, for accounting purposes, the Business Combination was treated as the equivalent of pre-combination AARK issuing stock for the net assets of ATI, accompanied by a recapitalization. The net assets of ATI have been stated at historical cost, with no goodwill or other intangible assets recorded. Operations prior to the Business Combination are those of pre-combination AARK and relate to the management consulting business.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Immediately following the Business Combination, there were <span id="xdx_900_eus-gaap--SharesOutstanding_iI_pip0_c20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zLc873t6gaFa" title="Shares Outstanding">15,257,666</span> Class A ordinary shares outstanding with a par value of $<span id="xdx_90A_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pip0_c20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zoLBNCME73Gd" title="Common stock, par value">0.0001</span>. Additionally, there were <span id="xdx_902_ecustom--PurchaseOfAdditionalShares_c20240401__20240930__us-gaap--AwardTypeAxis__custom--PrivatePlacementWarrantsMember_zbU6zgxCeJug" title="Purchase of additional shares">9,527,810</span> Private Placement Warrants (defined below) and <span id="xdx_90B_ecustom--PurchaseOfAdditionalShares_pip0_c20240401__20240930__us-gaap--AwardTypeAxis__custom--PublicWarrantsMember_zgIAXeR0MvW3" title="Purchase of additional shares">11,499,991</span> Public Warrants (defined below) outstanding with a right to purchase <span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightOutstanding_c20240930_zNHNld3HjYh3" title="Warrants outstanding">21,027,801</span> Class A ordinary shares.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Upon closing of the Business Combination, the total number of ATI’s Class A ordinary shares issued and outstanding was <span id="xdx_90D_eus-gaap--SharesOutstanding_iI_pip0_c20240930__us-gaap--StatementEquityComponentsAxis__custom--ClassAOrdinarySharesMember_z6DntwQbpJF6" title="Shares Outstanding"><span id="xdx_900_eus-gaap--SharesIssued_iI_pip0_c20240930__us-gaap--StatementEquityComponentsAxis__custom--ClassAOrdinarySharesMember_zkhJ8r02uCMc" title="Shares issued">15,257,666</span></span>. Further, certain Class A ordinary shareholders entered into non-redemption agreements executed on November 3, 2023 and November 5, 2023, to reverse redemptions for an aggregate of 1,652,892 Class A ordinary shares while waiving their right to receive any “Bonus Shares” issued under the Merger Agreement. In connection with the closing, holders of <span id="xdx_907_ecustom--RedemptionOfShares_c20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zBcsJc5f3oU6" title="Redemption of shares">2,697,052</span> Class A ordinary shares of ATI were redeemed at a price per share of approximately $10.69. AARK incurred approximately $<span id="xdx_907_eus-gaap--BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_iI_pn3n3_c20240930_zGXQHkVVm485" title="Transaction costs relating to business combination">3,697</span> in transaction costs relating to the Business Combination and recorded those costs against additional paid-in capital in the condensed consolidated balance sheet.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The number of Class A ordinary shares issued and outstanding immediately following the consummation of the Business Combination were:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--ScheduleOfconsummationOfBusinessCombinationTableTextBlock_pn3n3_zL5HGTAV4pe1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Nature of Operations (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8B9_zKbsPv82s0t4" style="display: none">Schedule of consummation of business combination</span></td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_490_20240930_zstfoLhjc3l8" style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr id="xdx_400_ecustom--PublicShareholdersRedeemableClassOrdinarySharesIncludingBonusShares_iI_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 88%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public Shareholders (Redeemable Class A ordinary shares), including Bonus Shares<sup id="xdx_F46_zMs8DCJ2AZn3">(1)</sup></span></td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 9%; text-align: right">3,157,469</td> <td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_ecustom--SharesHeldByWorldwideWebbAcquisitionSponsorLlcSponsorAndOtherInitialHolders_iI_pdd" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares held by Worldwide Webb Acquisition Sponsor, LLC (the “Sponsor”) and other initial holders<sup id="xdx_F4A_zopZJ6ZKuzog">(2)(3)</sup></span></td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">2,750,000</td> <td style="text-align: left"> </td></tr> <tr id="xdx_401_ecustom--SharesHeldByInnovoConsultancyDmcc_iI_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares held by Innovo Consultancy DMCC<sup id="xdx_F4A_zKTluDHViwV">(4)</sup></span></td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">5,638,530</td> <td style="text-align: left"> </td></tr> <tr id="xdx_40B_ecustom--SharesHeldByFpaHolders_iI_pdd" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares held by FPA (as defined below) Holders<sup id="xdx_F42_zRkc8uLDZna7">(5)</sup></span></td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; text-align: right">3,711,667</td> <td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--SharesIssued_iI_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; padding-bottom: 2.5pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total<sup id="xdx_F4D_z76toLVO4yyc">(6)</sup></b></span></td> <td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">15,257,666</td> <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <div style="width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt"> </div></div> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif"> <td id="xdx_F09_zLAMXiGfdJki" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in">(1)</td> <td id="xdx_F1B_z29IuixCi3q1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"> Includes 87,133 Bonus Shares issued to the Company’s public shareholders and 1,024,335 “Extension Shares” issued to certain holders of Class A ordinary shares (the “Holders”) in accordance with the Non-Redemption Agreement entered into between WWAC, the Sponsor, and the Holders of Class A ordinary shares. Also includes 288,333 shares purchased by the Forward Purchase Agreement (“FPA”) holders in the open market or via redemption reversals prior to the consummation of the Business Combination.</td> </tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td id="xdx_F08_zt03xZpuD88k" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">(2)</td> <td id="xdx_F15_zhz4A4LWJdMi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"> Includes 1,500,000 Class A ordinary shares issued to the Sponsor and 1,250,000 Class A ordinary shares issued to certain anchor investors upon conversion of Class B ordinary shares concurrently with the consummation of the Business Combination. 3,000,000 Class B ordinary shares were forfeited by the Sponsor upon the consummation of the Business Combination.</td> </tr> </table> <p style="margin: 0"> </p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif"> <td id="xdx_F06_zdBckcWUaGCf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in">(3)</td> <td id="xdx_F1D_zT06EfU9PPW6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"> Does not include (i) 1,500,000 Class B ordinary shares forfeited upon the consummation of the Business Combination, or (ii) 1,500,000 Class B ordinary shares forfeited pursuant to a Support Agreement with the Sponsor.</td> </tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td id="xdx_F04_z9Asfl7ITQh7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">(4)</td> <td id="xdx_F17_zThfhvSO4p6i" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"> Includes (i) 3,000,000 Class A ordinary shares reissued against 3,000,000 Class B ordinary shares forfeited by the Sponsor upon consummation of the Business Combination as per (2) above, and (ii) 2,638,530 remaining Bonus Shares issued to Innovo.</td> </tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td id="xdx_F06_zwkqKBkYo4Wk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">(5)</td> <td id="xdx_F11_zwYt5R1rFh27" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"> Represents a new issuance of Class A ordinary shares to the Forward Purchase Agreement holders in accordance with the Forward Purchase Agreement.</td> </tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td id="xdx_F09_zh8VE8AJWqsf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">(6)</td> <td id="xdx_F12_zHxElwOZS0jd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"> Does not include 10,000 AARK ordinary shares and 655,788 Aeries Technology Group Business Accelerators Private Limited’s ordinary shares that represent noncontrolling interest in AARK. These shares will be exchangeable (together with the proportionate reduction in the voting power of the Class V ordinary share, and in the case of the exchange of all AARK ordinary shares, the forfeiture and cancellation of the Class V ordinary share) into shares in Aeries Technology, Inc. in connection with the Exchange Agreements, which is further discussed in Note 10.</td> </tr> </table> <p id="xdx_8A0_zUeLfXLnFtQ7" style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As a result of the Business Combination, the Company’s Class A ordinary shares trade under the ticker symbol “AERT” and its public warrants (the “Public Warrants”) trade under the ticker symbol “AERTW” on the Nasdaq Stock Market. Prior to the consummation of the Business Combination, the Company’s Class A ordinary shares were traded on the Nasdaq Stock Market under the symbol “WWAC.”</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p>
CY2024Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	21027801	shares
CY2024Q3	us-gaap	Business Acquisition Cost Of Acquired Entity Transaction Costs BusinessAcquisitionCostOfAcquiredEntityTransactionCosts	3697000	usd
CY2024Q3	aert	Public Shareholders Redeemable Class Ordinary Shares Including Bonus Shares PublicShareholdersRedeemableClassOrdinarySharesIncludingBonusShares	3157469	shares
CY2024Q3	aert	Shares Held By Worldwide Webb Acquisition Sponsor Llc Sponsor And Other Initial Holders SharesHeldByWorldwideWebbAcquisitionSponsorLlcSponsorAndOtherInitialHolders	2750000	shares
CY2024Q3	aert	Shares Held By Innovo Consultancy Dmcc SharesHeldByInnovoConsultancyDmcc	5638530	shares
CY2024Q3	aert	Shares Held By Fpa Holders SharesHeldByFpaHolders	3711667	shares
CY2024Q3	us-gaap	Shares Issued SharesIssued	15257666	shares
	us-gaap	Profit Loss ProfitLoss	-17623000	usd
CY2024Q3	aert	Working Capital Deficit WorkingCapitalDeficit	9776000	usd
	us-gaap	Sale Of Stock Consideration Received Per Transaction SaleOfStockConsiderationReceivedPerTransaction	8000000	usd
	aert	Owed Balance OwedBalance	7500000	usd
	aert	Revenue Loss RevenueLoss	11500000	usd
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3627000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84C_eus-gaap--UseOfEstimates_zNoeuo5uobb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_86F_zvWKxYuoljch">Use of Estimates</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of condensed consolidated financial statements in accordance with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenue and expenses during the reporting periods. Significant items subject to such estimates and assumptions include, but are not limited to, revenue recognition, allowance for credit losses, stock-based compensation, fair valuation of FPA put option liabilities and private warrant liabilities, useful lives of property and equipment, accounting for income taxes, determination of incremental borrowing rates used for operating lease liabilities and right-of-use assets, obligations related to employee benefits and carve-out of financial statements, including the allocation of assets, liabilities and expenses. Management believes that the estimates and judgments upon which it relies, are reasonable based upon information available to the Company at the time that these estimates and judgments were made. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p>
	aert	Redemption Shares RedemptionShares	288333	shares
CY2024Q3	aert	Prepayment Amount PrepaymentAmount	42760000	usd
	us-gaap	Derivatives Methods Of Accounting Nonhedging Derivatives DerivativesMethodsOfAccountingNonhedgingDerivatives	<p id="xdx_847_eus-gaap--DerivativesMethodsOfAccountingNonhedgingDerivatives_zRoezQawM7ea" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_868_zd3gvbb0uJCi">Derivative Financial Instruments and FPA Put Option Liability</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company accounts for the Warrants (defined below) in accordance with the guidance contained in ASC 815-40 under which the Instruments (as defined below) do not meet the criteria for equity treatment and must be recorded as liabilities. The Company accounts for the FPA put option liability as a financial liability in accordance with the guidance in ASC 480-10. Warrants and FPA are collectively referred as the “Instruments”. The Instruments are subjected to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s condensed consolidated statement of operations. See Note 11 for further discussion of the pertinent terms of the Warrants and Note 14 for further discussion of the methodology used to determine the value of the Warrants and FPA.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In December 2023, the Company settled vendor balances mounting to $<span id="xdx_90D_ecustom--SettlementOfAccountsPayableThroughIssuanceOfSharesToVendors_c20231201__20231231_pn3n3" title="Settlement of accounts payable through issuance of Class A ordinary shares to vendors">855</span> owed to certain vendors by issuing <span id="xdx_90C_eus-gaap--SharesIssued_c20240930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_pdd" title="Shares issued">361,388</span> Class A ordinary shares. If the volume weighted average price (“VWAP”) of the Class A ordinary shares over the three trading days immediately preceding the agreement date is higher than the VWAP over the three trading days immediately preceding the six-month anniversary from the agreement date, additional Class A ordinary shares of ATI would need to be issued for the difference. This represents a derivative financial instrument written by the Company which has been accounted for in accordance with the guidance contained in ASC 815-40 including subsequent re-measurement at fair value with the changes being recognized in Company’s condensed consolidated statement of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"> <tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"></td> <td style="width: 0.25in; text-align: left">●</td> <td style="text-align: justify">For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value at inception and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the condensed consolidated balance sheets as current or noncurrent based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date. The Company is required to settle its liabilities under the FPAs by November 6, 2024. The total amount payable under the agreements is $<span id="xdx_90F_ecustom--SettlementOfAccountsPayableThroughCashOrInEquity_c20241101__20241106__us-gaap--TypeOfArrangementAxis__custom--ForwardPurchaseAgreementMember_pdd" title="Settlement of accounts payable through cash or in equity">8,000</span>, which may be settled either in cash or in equity, at the option of the investors.</td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p>
CY2023Q4	aert	Settlement Of Accounts Payable Through Issuance Of Shares To Vendors SettlementOfAccountsPayableThroughIssuanceOfSharesToVendors	855000	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_841_eus-gaap--ConcentrationRiskCreditRisk_z0RlGuU63HV7" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_86B_zKMJNUQOHG26">Concentration of Credit Risk</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Financial instruments that potentially subject the Company to credit risk consist primarily of cash and cash equivalents, accounts receivable, loans to affiliates, and investments. The Company holds cash at financial institutions that the Company believes are high credit quality financial institutions and limits the amount of credit exposure with any one bank and conducts ongoing evaluations of the creditworthiness of the banks with which it does business. As of September 30, 2024 and March 31, 2024, there was one customer that represented 10% or greater of the Company’s accounts receivable balance. The Company expects limited credit risk arising from its long-term investments as these primarily entail investments in the Company’s affiliates that have a credit rating that is above the minimum allowable credit rating defined in the Company’s investment policy. As a part of its risk management process, the Company limits its credit risk with respect to long-term investments by performing periodic evaluations of the credit standing of counterparties to its investments.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In respect of the Company’s revenue, there were two and three customers that each accounted for more than <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_c20240701__20240930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_pdd" title="Concentration of credit risk, percentage"><span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_c20230701__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_pdd" title="Concentration of credit risk, percentage">10%</span></span> of total revenue for the three months ended September 30, 2024 and 2023, respectively; and there were three customers that accounted for more than <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_c20240401__20240930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_pdd" title="Concentration of credit risk, percentage"><span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_c20230401__20230930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_pdd" title="Concentration of credit risk, percentage">10%</span></span> of total revenue for the six months ended September 30, 2024 and 2023. The following table shows the amount of revenue derived from each customer exceeding <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_c20240401__20240930__srt--MajorCustomersAxis__custom--CustomerMember_pdd" title="Concentration of credit risk, percentage"><span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_c20230401__20230930__srt--MajorCustomersAxis__custom--CustomerMember_pdd" title="Concentration of credit risk, percentage">10%</span></span> of the Company’s revenue during the three and six months ended September 2024 and 2023:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ScheduleOfCededCreditRiskByReinsurerTextBlock_pn3n3_zQeq4i8gSned" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8B1_zGZQcmYosH48" style="display: none">Schedule of concentration of credit risk</span></td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td> </td> <td style="vertical-align: bottom; text-align: right"> </td> <td style="text-align: left; vertical-align: bottom"> </td> <td> </td> <td> </td> <td style="vertical-align: bottom; text-align: right"> </td> <td style="text-align: left; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"> </td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Three Months Ended<br/> September 30,</td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"><b>Six Months Ended<br/> September 30,</b></td> <td style="text-align: left; padding-bottom: 1pt; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><b> </b></td> <td style="font-weight: bold; padding-bottom: 1pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>2024</b></td> <td style="padding-bottom: 1pt; font-weight: bold"><b> </b></td> <td style="font-weight: bold; padding-bottom: 1pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><b>2023</b></td> <td style="padding-bottom: 1pt; font-weight: bold"><b> </b></td> <td style="padding-bottom: 1pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>2024</b></td> <td style="text-align: left; vertical-align: bottom"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>2023</b></td> <td style="text-align: left; padding-bottom: 1pt; vertical-align: bottom"><b> </b></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 52%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer 1</span></td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 9%; text-align: right"><span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20240701__20240930__srt--MajorCustomersAxis__custom--CustomerOneMember_zmZVmFjma3Dl" title="Concentration of credit risk, percentage">16</span></td> <td style="width: 1%; text-align: left">%</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 9%; text-align: right"><span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230701__20230930__srt--MajorCustomersAxis__custom--CustomerOneMember_z2QfhfFYaBI8" title="Concentration of credit risk, percentage">15</span></td> <td style="width: 1%; text-align: left">%</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="vertical-align: bottom; text-align: right; width: 9%"><span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20240401__20240930__srt--MajorCustomersAxis__custom--CustomerOneMember_z1O8D00Rgka1" title="Concentration of credit risk, percentage">16</span></td> <td style="text-align: left; width: 1%; vertical-align: bottom">%</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="vertical-align: bottom; text-align: right; width: 9%"><span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230401__20230930__srt--MajorCustomersAxis__custom--CustomerOneMember_zRNH6YjVzzSk" title="Concentration of credit risk, percentage">15</span></td> <td style="text-align: left; width: 1%; vertical-align: bottom">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer 2</span></td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20240701__20240930__srt--MajorCustomersAxis__custom--CustomerTwoMember_zerb65mLJb7e" title="Concentration of credit risk, percentage">12</span></td> <td style="text-align: left">%</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230701__20230930__srt--MajorCustomersAxis__custom--CustomerTwoMember_zZy2uA6cVOCi" title="Concentration of credit risk, percentage">13</span></td> <td style="text-align: left">%</td> <td> </td> <td> </td> <td style="vertical-align: bottom; text-align: right"><span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20240401__20240930__srt--MajorCustomersAxis__custom--CustomerTwoMember_zQS7G7GUgtwa" title="Concentration of credit risk, percentage">12</span></td> <td style="text-align: left; vertical-align: bottom">%</td> <td> </td> <td> </td> <td style="vertical-align: bottom; text-align: right"><span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230401__20230930__srt--MajorCustomersAxis__custom--CustomerTwoMember_zSMZB19WVF7c" title="Concentration of credit risk, percentage">13</span></td> <td style="text-align: left; vertical-align: bottom">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer 3</span></td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">n/a</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230701__20230930__srt--MajorCustomersAxis__custom--CustomerThreeMember_zJOkUzmgckH6" title="Concentration of credit risk, percentage">10</span></td> <td style="text-align: left">%</td> <td> </td> <td> </td> <td style="vertical-align: bottom; text-align: right"><span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20240401__20240930__srt--MajorCustomersAxis__custom--CustomerThreeMember_zMsQWofB2vm2" title="Concentration of credit risk, percentage">10</span></td> <td style="text-align: left; vertical-align: bottom">%</td> <td> </td> <td> </td> <td style="vertical-align: bottom; text-align: right"><span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230401__20230930__srt--MajorCustomersAxis__custom--CustomerThreeMember_zsLBgVtauXwh" title="Concentration of credit risk, percentage">11</span></td> <td style="text-align: left; vertical-align: bottom">%</td></tr> </table> <p id="xdx_8AC_zZQG0STCHvS7" style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p>
CY2024Q3	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	4482000	usd
CY2024Q1	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	6778000	usd
	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.0080	pure
	aert	Insurance For Its Directors InsuranceForItsDirectors	After the Closing Date, ATI obtained an insurance policy for its directors and senior officers with maximum coverage of $5,000. The total premium payable in relation to this was $880 out of which $176 was paid upfront and balance $704 is payable in ten equal monthly instalments of $73. The arrangement represents a financing transaction where the premium payable has been deferred. The interest rate under the arrangement is 9.2% per annum. The cumulative interest payable throughout the tenure under the arrangement amounts to $30 and the same would be recognized as part of the interest expense in the condensed consolidated statement of operations. During the three and six months ended September 30, 2024, the interest expense so recognized was $2 and $9, respectively. The balance premium payable as at September 30, 2024 is Nil0.
CY2024Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	2000	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	9000	usd
CY2024Q3	aert	Premium Payable PremiumPayable	0	usd
CY2024Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	1514000	usd
CY2024Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	1440000	usd
CY2022Q4	aert	Exchange Rate ExchangeRate	137000	usd
CY2022Q4	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.1075	pure
CY2022Q4	us-gaap	Debt Instrument Term DebtInstrumentTerm	P48M
CY2024Q3	aert	Exchange Rate ExchangeRate	97000	usd
CY2024Q3	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.1025	pure
CY2024Q3	us-gaap	Debt Instrument Term DebtInstrumentTerm	P48M
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Rolling Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths	11000	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo	854000	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree	599000	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Two And Three LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwoAndThree	12000	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingAfterYearFive	61000	usd
CY2024Q3	us-gaap	Long Term Debt LongTermDebt	1537000	usd
CY2024Q3	us-gaap	Revenues Revenues	16873000	usd
CY2023Q3	us-gaap	Revenues Revenues	17578000	usd
	us-gaap	Revenues Revenues	33540000	usd
	us-gaap	Revenues Revenues	33908000	usd
CY2024Q3	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	863000	usd
CY2024Q1	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	255000	usd
	us-gaap	Deferred Income Revenue Recognized DeferredIncomeRevenueRecognized	210000	usd
	us-gaap	Deferred Income Revenue Recognized DeferredIncomeRevenueRecognized	142000	usd
CY2024Q3	us-gaap	Deferred Revenue DeferredRevenue	168000	usd
CY2024Q1	us-gaap	Deferred Revenue DeferredRevenue	261000	usd
CY2024Q3	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	0	usd
CY2024Q1	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	0	usd
CY2024Q3	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax	109000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax	29000	usd
	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax	154000	usd
	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax	114000	usd
CY2024Q3	aert	Amortization Of Net Actuarial Loss Gain AmortizationOfNetActuarialLossGain	-19000	usd
CY2023Q3	aert	Amortization Of Net Actuarial Loss Gain AmortizationOfNetActuarialLossGain	-21000	usd
	aert	Amortization Of Net Actuarial Loss Gain AmortizationOfNetActuarialLossGain	-36000	usd
	aert	Amortization Of Net Actuarial Loss Gain AmortizationOfNetActuarialLossGain	-43000	usd
CY2024Q3	aert	Deferred Tax Expense Benefit DeferredTaxExpenseBenefit	-26000	usd
CY2023Q3	aert	Deferred Tax Expense Benefit DeferredTaxExpenseBenefit	-2000	usd
	aert	Deferred Tax Expense Benefit DeferredTaxExpenseBenefit	-33000	usd
	aert	Deferred Tax Expense Benefit DeferredTaxExpenseBenefit	-18000	usd
CY2024Q3	aert	Unrecognized Actuarial Loss Gain On Employee Benefit Plan Obligations UnrecognizedActuarialLossGainOnEmployeeBenefitPlanObligations	64000	usd
CY2023Q3	aert	Unrecognized Actuarial Loss Gain On Employee Benefit Plan Obligations UnrecognizedActuarialLossGainOnEmployeeBenefitPlanObligations	6000	usd
	aert	Unrecognized Actuarial Loss Gain On Employee Benefit Plan Obligations UnrecognizedActuarialLossGainOnEmployeeBenefitPlanObligations	85000	usd
	aert	Unrecognized Actuarial Loss Gain On Employee Benefit Plan Obligations UnrecognizedActuarialLossGainOnEmployeeBenefitPlanObligations	53000	usd
CY2024Q3	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	145000	usd
CY2023Q3	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	113000	usd
	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	269000	usd
	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	226000	usd
CY2024Q3	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	41000	usd
CY2023Q3	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	25000	usd
	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	80000	usd
	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	49000	usd
CY2024Q3	aert	Defined Benefit Plan Amortization Losses DefinedBenefitPlanAmortizationLosses	19000	usd
CY2023Q3	aert	Defined Benefit Plan Amortization Losses DefinedBenefitPlanAmortizationLosses	21000	usd
	aert	Defined Benefit Plan Amortization Losses DefinedBenefitPlanAmortizationLosses	36000	usd
	aert	Defined Benefit Plan Amortization Losses DefinedBenefitPlanAmortizationLosses	43000	usd
CY2024Q3	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	205000	usd
CY2023Q3	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	159000	usd
	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	385000	usd
	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	318000	usd
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.084	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.387	pure
CY2024Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.186	pure
CY2023Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.423	pure
CY2020Q3	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	59900	shares
CY2023	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	59900	shares
CY2019Q3	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	295565	shares
	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P3Y6M
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.4080	pure
	aert	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumption Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionRiskFreeInterestRate	0.0301	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0000	pure
	aert	Unrecognized Stockbased Compensation Cost UnrecognizedStockbasedCompensationCost	0	usd
	aert	Unrecognized Stockbased Compensation Cost UnrecognizedStockbasedCompensationCost	0	usd
	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	200000	shares
CY2024Q3	aert	Exchange Rate ExchangeRate	2387000	usd
	us-gaap	Other Noncash Income OtherNoncashIncome	0	usd
	us-gaap	Other Noncash Income OtherNoncashIncome	2000	usd
	aert	Initial Public Offering Description InitialPublicOfferingDescription	the consummation of the Initial Public Offering, the Company issued 11,499,991 Public Warrants. Simultaneously with the closing of the Initial Public Offering, WWAC issued 8,900,000 warrants in a private placement (the “Private Placement Warrants”), at a purchase price of $1.00 per Private Placement Warrant, which included 900,000 units as a result of the underwriter’s full exercise of its option to purchase up to 900,000 additional warrants, at a purchase price of $1.00 per Private Placement Warrant. On November 6, 2023, WWAC issued 627,810 other Private Placement Warrants to the Sponsor pursuant to the conversion of a promissory note payable to the Sponsor. Upon consummation of the Business Combination, the Company assumed 11,499,991 Public Warrants and 9,527,810 Private Placement Warrants (collectively the “Warrants”).
CY2024Q3	aert	Sale Price SalePrice	18.00
CY2024Q3	aert	Sale Price SalePrice	18.00
CY2024Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2024Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	0.0001	shares
CY2023Q2	us-gaap	Stock Issued During Period Shares Stock Splits StockIssuedDuringPeriodSharesStockSplits	10000	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10000	shares
	aert	Revenue Loss RevenueLoss	11500000	usd
	aert	Buyout Revenue BuyoutRevenue	3100000	usd
	us-gaap	Schedule Of Repurchase Agreements ScheduleOfRepurchaseAgreements	<table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--ScheduleOfRepurchaseAgreements_pn3n3_zbjYUMcVH9cb" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Fair Value Measurements (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8BE_zRVmQATSifUf" style="display: none">Schedule of purchase agreement</span></td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 88%; text-align: left">Expected Term (Years)</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 9%; text-align: right"><span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240401__20240930__us-gaap--ClassOfWarrantOrRightAxis__custom--ForwardPurchaseAgreementPutOptionLiabilityMember_z4rM6HIZRSn7" title="Expected Term (Years)">0.1</span></td> <td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Risk free Interest Rate</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_c20240401__20240930__us-gaap--ClassOfWarrantOrRightAxis__custom--ForwardPurchaseAgreementPutOptionLiabilityMember_zRPVEz8T6hp" title="Risk-free interest rate">4.7</span></td> <td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top">Volatility</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_c20240401__20240930__us-gaap--ClassOfWarrantOrRightAxis__custom--ForwardPurchaseAgreementPutOptionLiabilityMember_z4PRoy3mjsqi" title="Volatility">35.0</span></td> <td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Reference Price for one Class A ordinary share</td> <td> </td> <td style="text-align: left">$</td> <td style="text-align: right"><span id="xdx_902_ecustom--ReferencePriceForOneShareOfClassCommonStock_pip0_c20240401__20240930__us-gaap--ClassOfWarrantOrRightAxis__custom--ForwardPurchaseAgreementPutOptionLiabilityMember_zSBybI4FHmQ9" title="Reference Price for one share of Class A common stock">2.3</span></td> <td style="text-align: left"> </td></tr> </table>
CY2024Q1	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs	11611000	usd
	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Gain Loss Included In Earnings FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings	1312000	usd
CY2024Q3	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs	10299000	usd
CY2024Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-2190000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-17011000	usd
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	44356074	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	44356074	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41121826	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41121826	shares
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.42
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.42
CY2024Q3	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001829126-24-007681-index-headers.html	Edgar Link	pending
0001829126-24-007681-index.html	Edgar Link	pending
0001829126-24-007681.txt	Edgar Link	pending
0001829126-24-007681-xbrl.zip	Edgar Link	pending
aeriestech_10q.htm	Edgar Link	pending
aeriestech_ex31-1.htm	Edgar Link	pending
aeriestech_ex31-2.htm	Edgar Link	pending
aeriestech_ex32-1.htm	Edgar Link	pending
aeriestech_ex32-2.htm	Edgar Link	pending
aert-20240930.xsd	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
aert-20240930_cal.xml	Edgar Link	unprocessable
aert-20240930_def.xml	Edgar Link	unprocessable
aert-20240930_lab.xml	Edgar Link	unprocessable
aert-20240930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
aeriestech_10q_htm.xml	Edgar Link	completed
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AERT
Aeries Technology, Inc. Stock $aert

2024 Q3 Form 10-Q Financial Statement

#000182912624007681 Filed on November 19, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AERT Aeries Technology, Inc. Stock $aert

2024 Q3 Form 10-Q Financial Statement

#000182912624007681 Filed on November 19, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AERT
Aeries Technology, Inc. Stock $aert